Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about NationDrugs.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Vi ville gerne vise dig en beskrivelse her, men det websted, du kigger på, tillader det ikke.
Physician reviewed ofatumumab patient information - includes ofatumumab description, dosage and directions.
Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.
The new england journal of medicine n engl j med 371;3 nejm.org17, 2014 july 213 original article Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid ...
What we do. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific ...
Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. (ASCLEPIOS II)
The purpose of this study is to evaluate the safety and efficacy of ofatumumab and bendamustine combination therapy in patients with indolent B-cell NHL that did not ...
The U.S. Food and Drug Administration (FDA) has approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab ...
A Phase 2 trial found that a subcutaneous formulation of ofatumumab is a safe and effective treatment at low doses for relapsing-remitting multiple sclerosis (RRMS).